Targeting Migrationsurvival And Immune Response Pathways In Cancer The Biokine Story Biokine Therapeutics Is A Private Biopharmaceutical Company Founded In 2000Biokine Lead Product Bkt140 Bl8040Is A High Affinitylong Acting Cxcr4 Receptor Inhibitor That Already Passed Successful Phase Iii For Stem Cell Mobilization And Phase I Ii For Immunotherapy For Cancer Together
No conferences found for this company.
| Company Name | Biokine Therapeutics Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
Enter your address and we will specify the offer for your area.